In vitro & in vivo correlation of release behavior of andrographolide from silica and PEG assisted silica gel matrix

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 455, Issue 1, 2014, Pages 111-121

  Chakraborty, Suparna ^a   Biswas, Supratim ^a   Sa, Biswanath ^a   Das, Satadal ^b   Dey, Rajib ^a  

^a JADAVPUR UNIVERSITY   (India)

^b PEERLESS HOSPITAL   (India)

Author keywords

Andrographolide; IVIVC; Nano porous silica gel; PEG; Sustained release

Indexed keywords

BIOCOMPATIBILITY; DRUG PRODUCTS; POLYETHYLENE GLYCOLS; SILICA; SILICA GEL; SOL-GEL PROCESS; TRANSMISSION ELECTRON MICROSCOPY;

ANDROGRAPHOLIDE; DIFFUSION MECHANISMS; FOURIER TRANSFORM INFRARED; HISTOLOGICAL EXAMINATION; IVIVC; NANO-POROUS; SUSTAINED RELEASE; VITRO-IN VIVO CORRELATION;

MATRIX ALGEBRA;

ANDROGRAPHOLIDE; MACROGOL; SILICA GEL; SILICON DIOXIDE;

ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORRELATIONAL STUDY; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84900033859     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2014.04.046     Document Type: Article

References (42)

1. Radin S., Chen T., Ducheyne The controlled release of drugs from emulsified, sol-gel processed silica microspheres. Biomaterials 2008, 30:850-858.
2. Lang Y., Finn P.D., Pandit A., Walsh J.P. Pharmacological activity of ibuprofen released from mesoporous silica. J. Mater. Sci.: Mater. Med. 2012, 23:73-80.
3. Munusamy P., Seleem N.M., Alqublan H., Tyler R., Sriranganathan N., Pickrell G. Targeted drug delivery using silica xerogel systems to treat diseases due to intracellular pathogens. Mater. Sci. Eng. C 2009, 29:2313-2318.
4. Gill I. Bio-doped nanocomposite polymers: sol-gel bioencapsulates. Chem. Mater. 2001, 13:3404-3421.
5. Paul G., Heimink J., Koller H. Controlling drug release of sol-gel encapsulated persantin and propranolol by surface interactions. Chem. Mater. 2008, 20:5083-5089.
6. Prokopowicz M., Łukasiak J. Synthesis and in vitro characterization of freeze-dried doxorubicin-loaded silica/PEG composite. J. Non-Cryst. Solids 2010, 356:1711-1720.
7. Das S.K.Md., Khan M.R., Guha A.K., Naskar N. Bio-inspired fabrication of silver nanoparticles on nanostructured silica: characterization and application as a highly efficient hydrogenation catalyst. Green Chem. 2013, 15:2548-2557.
8. Alfieri I. Sol-gel silicon alkoxides-polyethylene glycol derived hybrids for drug delivery systems. J. Appl. Biomater. Biomed. 2010, 8:14-19.
9. Brinker C.J., Scherer G.W. Sol-Gel Science: The Physics and Chemistry of Sol-Gel Processing 1990, Academic Press, San Diego, CA.
10. Pei L., Kurumada K., Tanigaki M., Hiro M., Susa K. Effect of drying on the mesoporous structure of sol-gel derived silica with PPO-PEO-PPO template block copolymer. J. Colloid Interface Sci. 2005, 284:222-227.
11. 2O aqueous biphasic system. Colloids Surf. A 2003, 226:45-54.
12. Mohammad B.J., Adibkia K., Valizadeh H., Shadbad M.R., Nokhodchi S., Omidi A.Y., Mohammadi G., Nezhad S.H., Hasan M. Kinetic analysis of drug release from nanoparticles. J. Pharm. Pharmaceut. Sci. 2008, 11:167-177.
13. Uppoor S.V.R. Regulatory perspectives on in-vitro (dissolution)/in-vivo (bioavailability) correlations. J. Control. Release 2001, 72:127-132.
14. Klein S., Markus R., Brigitte S., Hans U.P., Jennifer D. Regulatory perspectives on in-vitro (dissolution)/in-vivo (bioavailability) correlations. J. Control. Release 2008, 130:216-219.
15. Patel F.V., Fang L., Marc B. Modeling the oral cavity: in-vitro and in-vivo evaluations of buccal drug delivery systems. J. Control. Release 2012, 161:746-756.
16. Roy P., Das S., Bera T., Mondol S., Mukherjee A. Andrographolide nanoparticles in leishmaniasis: characterization and in-vitro evaluations. Int. J. Nanomed. 2010, 5:1113-1121.
17. Radin S., Ducheyne P. Nano structural control of implantable xerogels for the controlled release of biomolecules. NATO Sci. Ser. II: Math. Phys. Chem. 2003, 171:59-74.
18. 17O-NMR of sol-gel processes of TEOS and TMOS. J. Sol-Gel Sci. Technol. 1998, 13:71-74.
19. Chakraborty S., Biswas S., Manna S.J., Das S., Dey R. Sol-gel derived silica-gel as a controlled delivery system of Andrographis paniculata extract and its anti-microbial efficacy. Trans. Indian Inst. Metals 2011, 64:189-193.
20. Singh N.K., Singh S.K., Dash D., Das P., Roy B.P., Maiti J.K. Nanostructure controlled anti-cancer drug delivery using poly (e{open}-caprolactone) based nanohybrids. J. Mater. Chem. 2012, 22:17853-17863.
21. Albarran L., Lopeza T., Quintanac P., Chagoyad V. Controlled release of IFC-305 encapsulated in silica nanoparticles for liver cancer synthesized by sol-gel. Colloid Surf. A 2011, 384:131-136.
22. Chakraborty S., Mitra M.K., Chaudhuri M.G., Sa B., Das S., Dey R. Study of the release mechanism of Terminalia chebula extract from nanoporous silica Gel. Appl. Biochem. Biotechnol. 2012, 168:2043-2056.
23. Shah U.S., Shah K., Rehman A., Khan M.G.P. Investigating the in-vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of coexcipients on drug release pattern. J. Pharmacol. Sci. 2011, 24:183-192.
24. Sankalia J.M., Sankalia M.G., Mashru R.C. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC. J. Control. Release 2008, 129:49-58.
25. Das Md.S.K., Khan M.R., Parandhaman T., Laffir F., Guha A.K., Sekaran G., Mandal A.B. Nano-silica fabricated with silver nanoparticles: antifouling adsorbent for efficient dye removal, effective water disinfection and biofouling control. Nanoscale 2013, 5:5549-5560.
26. Vadia N., Rajput S. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement. Eur. J. Pharm. Sci. 2012, 45:8-18.
27. Vijayalakshmi U.U., Balamurugan A., Rajeswari S. Synthesis and characterization of porous silica gels for biomedical applications. Trends Biomater. Artif. Organs 2005, 18:101-105.
28. Singh P., Gupta U., Asthana A., Jain N.K. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Bioconjug. Chem. 2008, 19:2239-2252.
29. 2 to methanol: effects of modification of silica gel and ADH on enzyme activity. Am. Chem. Soc. Div. Fuel Chem. 2004, 49:120-121.
30. Xu H.W., Dai G.F., Liu G.Z., Wang J.F., Liu H.M. Synthesis of Andrographolide derivatives: a new family of a-glucosidase inhibitors. Bioorg. Med. Chem. 2007, 15:4247-4255.
31. Nampi P.P., Mohan S.V., Sinha K.A., Varma H. High surface area sol-gel nano silica as a novel drug carrier substrate for sustained drug release. Mater. Res. Bull. 2012, 47:1379-1384.
32. Gaetano F.D., Ambrosio L., Raucci M.G., Marotta A., Catauro M. Sol-gel processing of drug delivery materials and release kinetics. J. Mater. Sci. Mater. Med. 2005, 16:261-265.
33. Czarnobaj K., Łukasiak J. In-vitro release of cisplatin from sol-gel processed organically modified silica xerogels. J. Mater. Sci. Mater. Med. 2007, 18:2041-2044.
34. Rosenholm M.J., Lindén M. Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications. J. Control Release 2008, 1281:57-164.
35. Bernkop A.S. Reprint of: Nano-carrier systems for oral drug delivery: do we really need them. Eur. J. Pharm. Sci. 2013, 50:2-7.
36. Barbè C., Bartlett J., Kong L., Finnie K., Lin H.Q., Larkin M., Calleja S., Bush A. Slica particles: a novel drug-delivery system. Adv. Mater. 2004, 16:1959-1966.
37. Shahnaz G., Iqbal J., Rahmat D., Perera G., Laffleur F., Rossi D., Schnürch B.A. Development and in vivo characterization of a novel peptide drug delivery system providing extended plasma halflife. J. Control Release 2012, 157:375-382.
38. Fernandes M.C., Ramos P., Falcao A.C., Veiga F. Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in-vitro evaluation and bioavailability studies in rabbits. J. Control Release 2003, 88:127-134.
39. Diego A.G., Philbrook M., Avila L.Z., Young L.E., Plate L., Santos M.R., Bernasconi R., Liu H., Ahn S., Sun W., Jarrett P.K., Miller R.J. Hyaluronan-tethered opioid depots: synthetic strategies and release kinetics in-vitro and in-vivo. Bioconjug. Chem. 2008, 19:1767-1774.
40. Cao X., Deng W., Fu M., Zhu Y., Liu H., Wang L., Zeng J., Wei Y., Xu X., Yu J. Seventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in-vitro release kinetics and in-vitro/in-vivo correlations in beagle dogs. Eur. J. Pharm. Sci. 2013, 48:64-71.
41. Faraji H.A., Wipf P. Nanoparticles in cellular drug delivery. Bioorg. Med. Chem. 2009, 17:2950-2962.
42. Kortesuo P., Aholal M., Karlsson S., Kangasniemi I., Yli U.A., Kiesvaara J. Silica xerogel as an implantable carrier for controlled drug delivery evaluation of drug distribution and tissue effects after implantation. Biomaterials 2000, 21:193-198.